These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12450787)

  • 21. Absence of t(12;15) associated ETV6-NTRK3 fusion transcripts in pediatric acute leukemias.
    Alessandri AJ; Knezevich SR; Mathers JA; Schultz KR; Sorensen PH
    Med Pediatr Oncol; 2001 Oct; 37(4):415-6. PubMed ID: 11568911
    [No Abstract]   [Full Text] [Related]  

  • 22. Associations and interactions between Ets-1 and Ets-2 and coregulatory proteins, SRC-1, AIB1, and NCoR in breast cancer.
    Myers E; Hill AD; Kelly G; McDermott EW; O'Higgins NJ; Buggy Y; Young LS
    Clin Cancer Res; 2005 Mar; 11(6):2111-22. PubMed ID: 15788656
    [TBL] [Abstract][Full Text] [Related]  

  • 23.
    Bastos AU; de Jesus AC; Cerutti JM
    Eur J Endocrinol; 2018 Jan; 178(1):83-91. PubMed ID: 29046324
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pan-TRK Immunohistochemistry: A Useful Diagnostic Adjunct For Secretory Carcinoma of the Breast.
    Harrison BT; Fowler E; Krings G; Chen YY; Bean GR; Vincent-Salomon A; Fuhrmann L; Barnick SE; Chen B; Hosfield EM; Hornick JL; Schnitt SJ
    Am J Surg Pathol; 2019 Dec; 43(12):1693-1700. PubMed ID: 31498178
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of the ETV6-NTRK3 chimeric RNA of infantile fibrosarcoma/cellular congenital mesoblastic nephroma in paraffin-embedded tissue: application to challenging pediatric renal stromal tumors.
    Argani P; Fritsch M; Kadkol SS; Schuster A; Beckwith JB; Perlman EJ
    Mod Pathol; 2000 Jan; 13(1):29-36. PubMed ID: 10658907
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutation of the salt bridge-forming residues in the ETV6-SAM domain interface blocks ETV6-NTRK3-induced cellular transformation.
    Cetinbas N; Huang-Hobbs H; Tognon C; Leprivier G; An J; McKinney S; Bowden M; Chow C; Gleave M; McIntosh LP; Sorensen PH
    J Biol Chem; 2013 Sep; 288(39):27940-50. PubMed ID: 23798677
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-resectable congenital tumors with the ETV6-NTRK3 gene fusion are highly responsive to chemotherapy.
    McCahon E; Sorensen PH; Davis JH; Rogers PC; Schultz KR
    Med Pediatr Oncol; 2003 May; 40(5):288-92. PubMed ID: 12652616
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic molecular pathology comes of age.
    el-Naggar AK
    Adv Anat Pathol; 1999 Nov; 6(6):324-6. PubMed ID: 10562894
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transcriptome sequencing identifies ETV6-NTRK3 as a gene fusion involved in GIST.
    Brenca M; Rossi S; Polano M; Gasparotto D; Zanatta L; Racanelli D; Valori L; Lamon S; Dei Tos AP; Maestro R
    J Pathol; 2016 Mar; 238(4):543-9. PubMed ID: 26606880
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NTRK fusion oncogenes in pediatric papillary thyroid carcinoma in northeast United States.
    Prasad ML; Vyas M; Horne MJ; Virk RK; Morotti R; Liu Z; Tallini G; Nikiforova MN; Christison-Lagay ER; Udelsman R; Dinauer CA; Nikiforov YE
    Cancer; 2016 Apr; 122(7):1097-107. PubMed ID: 26784937
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prediction of EVT6-NTRK3-Dependent Papillary Thyroid Cancer Using Minor Expression Profile.
    Kechin AA; Ivanov AA; Kel AE; Kalmykov AS; Oskorbin IP; Boyarskikh UA; Kharpov EA; Bakharev SY; Oskina NA; Samuilenkova OV; Vikhlyanov IV; Kushlinskii NE; Filipenko ML
    Bull Exp Biol Med; 2022 Jun; 173(2):252-256. PubMed ID: 35737155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Response to Cabozantinib Following Acquired Entrectinib Resistance in a Patient With
    Hanf D; Heining C; Laaber K; Nebelung H; Uhrig S; Hutter B; Jahn A; Richter D; Aust D; Herbst F; Fröhling S; Glimm H; Folprecht G
    JCO Precis Oncol; 2021; 5():. PubMed ID: 34250401
    [No Abstract]   [Full Text] [Related]  

  • 33. Translocation-associated salivary gland tumors: a review and update.
    Weinreb I
    Adv Anat Pathol; 2013 Nov; 20(6):367-77. PubMed ID: 24113307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mammary analogue secretory carcinoma of salivary glands: a clinicopathologic and molecular study including 2 cases harboring ETV6-X fusion.
    Ito Y; Ishibashi K; Masaki A; Fujii K; Fujiyoshi Y; Hattori H; Kawakita D; Matsumoto M; Miyabe S; Shimozato K; Nagao T; Inagaki H
    Am J Surg Pathol; 2015 May; 39(5):602-10. PubMed ID: 25651470
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TrkC plays an essential role in breast tumor growth and metastasis.
    Jin W; Kim GM; Kim MS; Lim MH; Yun C; Jeong J; Nam JS; Kim SJ
    Carcinogenesis; 2010 Nov; 31(11):1939-47. PubMed ID: 20802235
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mammary Analogue Secretory Carcinoma of Salivary Glands: Molecular Analysis of 25 ETV6 Gene Rearranged Tumors With Lack of Detection of Classical ETV6-NTRK3 Fusion Transcript by Standard RT-PCR: Report of 4 Cases Harboring ETV6-X Gene Fusion.
    Skálová A; Vanecek T; Simpson RH; Laco J; Majewska H; Baneckova M; Steiner P; Michal M
    Am J Surg Pathol; 2016 Jan; 40(1):3-13. PubMed ID: 26492182
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fusion of ETV6 to fibroblast growth factor receptor 3 in peripheral T-cell lymphoma with a t(4;12)(p16;p13) chromosomal translocation.
    Yagasaki F; Wakao D; Yokoyama Y; Uchida Y; Murohashi I; Kayano H; Taniwaki M; Matsuda A; Bessho M
    Cancer Res; 2001 Dec; 61(23):8371-4. PubMed ID: 11731410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A fluorescence in situ hybridization study of ETV6-NTRK3 fusion gene in secretory breast carcinoma.
    Makretsov N; He M; Hayes M; Chia S; Horsman DE; Sorensen PH; Huntsman DG
    Genes Chromosomes Cancer; 2004 Jun; 40(2):152-7. PubMed ID: 15101049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TEL and MN1 fusion in myelodysplastic syndrome: new evidence for a therapy-related event.
    Vieira L; Marques B; Ambrósio AP; Chumbo M; Reis AB; Júnior EC; Boavida MG
    Br J Haematol; 2000 Jul; 110(1):238-9. PubMed ID: 10931009
    [No Abstract]   [Full Text] [Related]  

  • 40. Oncogenic TRK fusions are amenable to inhibition in hematologic malignancies.
    Taylor J; Pavlick D; Yoshimi A; Marcelus C; Chung SS; Hechtman JF; Benayed R; Cocco E; Durham BH; Bitner L; Inoue D; Chung YR; Mullaney K; Watts JM; Diamond EL; Albacker LA; Mughal TI; Ebata K; Tuch BB; Ku N; Scaltriti M; Roshal M; Arcila M; Ali S; Hyman DM; Park JH; Abdel-Wahab O
    J Clin Invest; 2018 Aug; 128(9):3819-3825. PubMed ID: 29920189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.